What happens when patients stop taking GLP-1 drugs? New Cleveland Clinic study reveals real world insights - EurekAlert!
GLP-1 drugs linked to lower addiction rates in large study of veterans
GLP-1 drugs like Ozempic could cut risk of major heart complications after heart attack, study finds - EurekAlert!
GLP-1 drugs associated with reduced need for emergency care for migraine - EurekAlert!
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients - EurekAlert!
The potential of GLP-1 drugs to transform medicine exploded in 2025
GLP-1 drugs failed to slow Alzheimer’s in two big clinical trials
Science briefing: An update on GLP-1 drugs for obesity - EurekAlert!
GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch
Research alert: GLP-1 drugs linked to dramatically lower death rates in colon cancer patients - EurekAlert!
GLP-1 drugs effective for weight loss, but more independent studies needed - EurekAlert!
A turning point in addiction psychiatry? GLP-1 drugs go far beyond weight loss and show a surprising ability to tame cravings for everything from alcohol to gambling.
Utah chemists discover enzyme that could help build next-generation GLP-1 drugs - EurekAlert!
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity - EurekAlert!
GLP-1 drugs reduce risk of death and hospitalization in patients with heart failure - EurekAlert!
GLP-1 drugs fail to provide key long-term health benefit - EurekAlert!
GLP-1 drugs are helpful for children who are living with severe obesity, data from Swedish clinic indicates - EurekAlert!
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer’s disease - EurekAlert!
Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer's disease
GLP-1 drugs are only the start – the powerful drugs to expect next
